255 related articles for article (PubMed ID: 27212224)
1. Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.
Murakami T; Ueba Y; Shinoto Y; Koga Y; Kaneda D; Hatoko T; Kato T; Yonemitsu S; Muro S; Oki S
Tohoku J Exp Med; 2016 Jun; 239(2):89-94. PubMed ID: 27212224
[TBL] [Abstract][Full Text] [Related]
2. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease.
Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P
J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451
[TBL] [Abstract][Full Text] [Related]
4. Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
Richter MM; Kemp IM; Heebøll S; Winther-Sørensen M; Kjeldsen SAS; Jensen NJ; Nybing JD; Linden FH; Høgh-Schmidt E; Boesen MP; Madsbad S; Schiødt FV; Nørgaard K; Schmidt S; Gluud LL; Haugaard SB; Holst JJ; Nielsen S; Rungby J; Wewer Albrechtsen NJ
Metabolism; 2024 Jul; 156():155915. PubMed ID: 38631460
[TBL] [Abstract][Full Text] [Related]
5. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children.
Riley LG; Nafisinia M; Menezes MJ; Nambiar R; Williams A; Barnes EH; Selvanathan A; Lichkus K; Bratkovic D; Yaplito-Lee J; Bhattacharya K; Ellaway C; Kava M; Balasubramaniam S; Christodoulou J
Mol Genet Metab; 2022 Jan; 135(1):63-71. PubMed ID: 34991945
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
[TBL] [Abstract][Full Text] [Related]
7. Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
Shin MY; Kim JM; Kang YE; Kim MK; Joung KH; Lee JH; Kim KS; Kim HJ; Ku BJ; Shong M
J Korean Med Sci; 2016 Sep; 31(9):1413-8. PubMed ID: 27510384
[TBL] [Abstract][Full Text] [Related]
8. Associations of FGF21 and GDF15 with mitochondrial dysfunction in children living with perinatally-acquired HIV: A cross-sectional evaluation of pediatric AIDS clinical trials group 219/219C.
Gojanovich GS; Jacobson DL; Broadwell C; Karalius B; Kirmse B; Geffner ME; Jao J; Van Dyke RB; McFarland EJ; Silio M; Crain M; Gerschenson M;
PLoS One; 2021; 16(12):e0261563. PubMed ID: 34972147
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease.
Koga Y; Povalko N; Inoue E; Nashiki K; Tanaka M
Mitochondrion; 2019 Sep; 48():11-15. PubMed ID: 30738201
[TBL] [Abstract][Full Text] [Related]
10. Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
Van Hove JLK; Friederich MW; Strode DK; Van Hove RA; Miller KR; Sharma R; Shah H; Estrella J; Gabel L; Horslen S; Kohli R; Lovell MA; Miethke AG; Molleston JP; Romero R; Squires JE; Alonso EM; Guthery SL; Kamath BM; Loomes KM; Rosenthal P; Mysore KR; Cavallo LA; Valentino PL; Magee JC; Sundaram SS; Sokol RJ;
Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38180987
[TBL] [Abstract][Full Text] [Related]
11. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
[TBL] [Abstract][Full Text] [Related]
12. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
13. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
[TBL] [Abstract][Full Text] [Related]
14. Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children.
Li Y; Li S; Qiu Y; Zhou M; Chen M; Hu Y; Hong S; Jiang L; Guo Y
Front Pediatr; 2022; 10():851534. PubMed ID: 35498801
[TBL] [Abstract][Full Text] [Related]
15. Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases.
Lovadi E; Csereklyei M; Merkli H; FüLöp K; Sebők Á; Karcagi V; Komoly S; Pál E
Muscle Nerve; 2017 Apr; 55(4):564-569. PubMed ID: 27489983
[TBL] [Abstract][Full Text] [Related]
16. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
[TBL] [Abstract][Full Text] [Related]
17. Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer's disease in comparison with healthy aging.
Conte M; Sabbatinelli J; Chiariello A; Martucci M; Santoro A; Monti D; Arcaro M; Galimberti D; Scarpini E; Bonfigli AR; Giuliani A; Olivieri F; Franceschi C; Salvioli S
Geroscience; 2021 Apr; 43(2):985-1001. PubMed ID: 33131010
[TBL] [Abstract][Full Text] [Related]
18. Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review.
Yuan D; Wu BJ; Henry A; Rye KA; Ong KL
Clin Endocrinol (Oxf); 2019 Jan; 90(1):47-55. PubMed ID: 30346647
[TBL] [Abstract][Full Text] [Related]
19. FGF21 in ataxia patients with spinocerebellar atrophy and mitochondrial disease.
Su SL; Wang WF; Wu SL; Wu HM; Chang JC; Huang CS; Cheng WL; Soong BW; Lee YC; Li JY; Kuo SJ; Chen M; Huang CN; Liu CS
Clin Chim Acta; 2012 Dec; 414():225-7. PubMed ID: 23031666
[TBL] [Abstract][Full Text] [Related]
20. Exenatide treatment decreases fasting fibroblast growth factor 21 levels in patients with newly diagnosed type 2 diabetes mellitus.
Hu Y; Liu J; Zhang H; Xu Y; Hong T; Wang G
Diabetes Metab; 2016 Nov; 42(5):358-363. PubMed ID: 27178737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
